Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

MLA

Moccia, M., et al. “Utilization of Peginterferon-β-1a in the Real-World Practice for Relapsing-Remitting Multiple Sclerosis.” European Review for Medical & Pharmacological Sciences, vol. 28, no. 1, Jan. 2024, pp. 411–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=175063721&authtype=sso&custid=ns315887.

APA

Moccia, M., Santoni, L., Vaccari, I., Affinito, G., Caliendo, D., Rubba, F., Lanzillo, R., Triassi, M., Morra, V. B., & Palladino, R. (2024). Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis. European Review for Medical & Pharmacological Sciences, 28(1), 411–418.

Chicago

Moccia, M., L. Santoni, I. Vaccari, G. Affinito, D. Caliendo, F. Rubba, R. Lanzillo, M. Triassi, V. Brescia Morra, and R. Palladino. 2024. “Utilization of Peginterferon-β-1a in the Real-World Practice for Relapsing-Remitting Multiple Sclerosis.” European Review for Medical & Pharmacological Sciences 28 (1): 411–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=175063721&authtype=sso&custid=ns315887.